7[5]Chu E,Callender MA,Farrell MP,Schmitz JC.Thymidylate synthase inhibitors as anticancer agents:from bench to bedside.Cancer Chemother Pharmacol 2003; 52 Suppl 1:S80-S89
8[6]Aschele C,Debernardis D,Casazza S,Antonelli G,Tunesi G,Baldo C,Lionetto R,Maley F,Sobrero A.Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy.J Clin Oncol 1999; 17:1760-1770
9[7]Cascinu S,Aschele C,Barni S,Debernardis D,Baldo C,Tunesi G,Catalano V,Staccioli MP,Brenna A,Muretto P,Catalano G.Thymidylate synthase protein expression in advanced colon cancer:correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.Clin Cancer Res 1999; 5:1996-1999
10[8]Kralovanszky J,Koves I,Orosz Z,Katona C,Toth K,Rahoty P,Czegledi F,Kovacs T,Budai B,Hullan L,Jeney A.Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors.Oncology 2002; 62:167-174
1Lee HJ,Nam KT, Park HS, et al. Gene expression profiling of metaplastie lineages identifies CDH17 as a prognostic marker in early stage gastric cancer[J]. Gastroenterology, 2010,139 ( 1 ): 213-225.
2Gimona M, Kaverina I, Resch GP, et al. Calponin repeats regulate aetin filament stability and formation of podosomes in smooth muscle cells[J]. Mol Biol Cell, 2003,14 (6) : 2482-2491.
3Sugaya A,Takeoka M, hano N, et al. Calponin h1-S175T point mutation enhances resistance to actin cytoskeleton perturbation in human cancer cells[J]. Anticancer Res, 2010,30 (4) : 1071- 1078.
4Ferjani I, Fattoum A, Manai M, et al. Two distinct regions of calponin share common binding sites on actin resulting in different modes of ealponin-aetin interaction [J ]. Bioehim Biophys Acta,2010,1804(9) :1760-1767.
5Ogura T, Kobayashi H, Ueoka Y, et al. Adenovirus-mediated calponin hl gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells[J]. Clin Cancer Res, 2006,12(17) :5216-5223.
6Castro MM,Cena J, Cho WJ, et al. Matrix metalloproteinase 2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats[J]. Arterioscler Thromb Vase Biol,2012,32(3) :662-668.
7BRAUN MS, RICHMAN SD,THOMPSON L, et al. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial [J]. J Clin Oncol,2009,27 (33) :5519 - 5528.
8KADAKOL A, GHOSH SS, SAPPAL BS, et al. Genetic lesions of bilirubin uidine-diphosphoglucuronate glucuronosyl transferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes correlation of genotype to phenotype [ J ]. Hum Mutat, 2000,16 (4) :297 -306.
9MARCUELLO E, ALTI-S A, MENOYO A, et al. UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer[ J]. Br J Cancer,2004,91 (4) :678 -682.
10ZHANG A, XING Q, QIN S, et al. Intra-ethnic differences in genetic variants of the UGT-glucuronosyl transferase IAI gene in Chinese populations [ J ]. Pharmacogenomics J, 2007, 7 ( 5 ) : 333 -338.
